The number of sequences necessary for statistically significant (p < 0.05, t-test) differentiation between wild-type and variant tumor markers was investigated for IDH1, IDH2, pTERT C228, and pTERT C250, as patient material with confirmed mutations was available. Here, IDH2 is linked to neoplasm.